Literature DB >> 11815764

Prognostic value of the neurologic optimality score at 9 and 18 months in preterm infants born before 31 weeks' gestation.

Maria Flavia Frisone1, Eugenio Mercuri, Sabrina Laroche, Christine Foglia, Elia F Maalouf, Leena Haataja, Frances Cowan, Lilly Dubowitz.   

Abstract

OBJECTIVE: The Hammersmith Infant Neurological Examination was performed in a cohort of 74 preterm infants whose gestational age ranged between 24 and 30.5 weeks. The infants were examined between 9 and 18 months' chronologic age (6-15 months' corrected age) and scored with the optimality score system previously standardized in a cohort of low-risk term infants. The aim of the study was to establish the frequency distribution of the optimality scores in this cohort and to establish whether the scores can predict locomotor function at 2 years of age.
RESULTS: The results showed that this standardized neurologic examination can be performed in preterm infants as early as 9 months' chronologic age to predict motor outcome at 2 years old. The scores showed no significant association with the degree of prematurity or the age of assessment.
CONCLUSION: This examination should be particularly useful in very premature infants who are at high risk of severe neurologic and developmental disabilities and for whom the early prediction of motor function can be difficult.

Entities:  

Mesh:

Year:  2002        PMID: 11815764     DOI: 10.1067/mpd.2002.119626

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  T2 relaxation values in the developing preterm brain.

Authors:  Serena J Counsell; Nigel L Kennea; Amy H Herlihy; Joanna M Allsop; Michael C Harrison; Frances M Cowan; Joseph V Hajnal; Bridget Edwards; A David Edwards; Mary A Rutherford
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

2.  Association between neonatal iron overload and early human brain development in premature infants.

Authors:  Sanjiv B Amin; Gary Myers; Hongyue Wang
Journal:  Early Hum Dev       Date:  2012-02-18       Impact factor: 2.079

3.  Implementation of the Hammersmith Infant Neurological Examination in a High-Risk Infant Follow-Up Program.

Authors:  Nathalie L Maitre; Olena Chorna; Domenico M Romeo; Andrea Guzzetta
Journal:  Pediatr Neurol       Date:  2016-09-21       Impact factor: 3.372

4.  Associations between regional brain volumes at term-equivalent age and development at 2 years of age in preterm children.

Authors:  Annika Lind; Riitta Parkkola; Liisa Lehtonen; Petriina Munck; Jonna Maunu; Helena Lapinleimu; Leena Haataja
Journal:  Pediatr Radiol       Date:  2011-05-02

5.  Usefulness of an early neurofunctional assessment in predicting neurodevelopmental outcome in very low birthweight infants.

Authors:  O Picciolini; M L Giannì; C Vegni; M Fumagalli; F Mosca
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03       Impact factor: 5.747

6.  A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years.

Authors:  Neil Marlow; Timothy Morris; Peter Brocklehurst; Robert Carr; Frances M Cowan; Nishma Patel; Stavros Petrou; Maggie E Redshaw; Neena Modi; Caroline Dore
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-04-27       Impact factor: 5.747

7.  Preliminary study of urinary arsenic concentration and arsenic methylation capacity effects on neurodevelopment in very low birth weight preterm children under 24 months of corrected age.

Authors:  Chuen-Bin Jiang; Yu-Mei Hsueh; Guang-Lin Kuo; Chyong-Hsin Hsu; Jui-Hsing Chang; Ling-Chu Chien
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

8.  Neurodevelopmental Outcome in Extremely Low Birth Weight Infants at 2-3 Years of Age.

Authors:  Maria Kyriakidou; Ilias Chatziioannidis; Georgios Mitsiakos; Sofia Lampropoulou; Abraham Pouliakis
Journal:  Medicina (Kaunas)       Date:  2020-11-26       Impact factor: 2.430

9.  Development of the forward parachute reaction and the age of walking in near term infants: a longitudinal observational study.

Authors:  Domenico M M Romeo; Matteo Cioni; Mariacristina Scoto; Filippo Palermo; Alessandra Pizzardi; Anna Sorge; Mario G Romeo
Journal:  BMC Pediatr       Date:  2009-02-16       Impact factor: 2.125

Review 10.  Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy.

Authors:  Qing Li
Journal:  Yonsei Med J       Date:  2020-04       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.